On May 6, 2025, Grifols SA announced the approval of a public purchase offer to acquire all ordinary shares of Biotest AG for EUR 43.00 each and non-voting preference shares for EUR 30.00 each, continuing from a previous announcement on March 31, 2025. The acceptance period for the offer runs until June 6, 2025.